Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)
China flag China · Delayed Price · Currency is CNY
32.08
+5.35 (20.01%)
Oct 23, 2026, 3:04 PM CST

SHE:300584 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
71.6442.0640.2236.3232.45285.88
Depreciation & Amortization
64.4464.4752.9353.5648.1437.06
Other Amortization
0.150.12---0.01
Loss (Gain) From Sale of Assets
-0.48-0.48-0.790.950.02
Asset Writedown & Restructuring Costs
4.44.42.090.040.922.56
Loss (Gain) From Sale of Investments
26.2926.29-0-0.06-1.05-306.42
Provision & Write-off of Bad Debts
0.370.37-0.851.654.07-
Other Operating Activities
-61.1812.116.9212.9611.156.51
Change in Accounts Receivable
-70.77-70.77-49.87-31.52-121.75-37.4
Change in Inventory
2.262.26-13.44-22-9.3717.48
Change in Accounts Payable
11.6811.6817.76-19.3357.1216.15
Operating Cash Flow
34.3878.0959.9623.93-5.8259.94
Operating Cash Flow Growth
-53.85%30.23%150.54%---18.32%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-28.94-62.64-77.94-197.22-218.94-94.41
Sale of Property, Plant & Equipment
-29.5629.50.010.650.080.04
Investment in Securities
-4-8.1059.31247.988.8
Investing Cash Flow
-62.5-41.24-77.93-137.2729.12-85.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-18.673.629.38283.97145
Long-Term Debt Issued
-234.3273.5305.24949.18
Total Debt Issued
298252.9347.1334.58332.97194.18
Short-Term Debt Repaid
--60.36-73.47---135
Long-Term Debt Repaid
--222.97-260.1-263.04-338.55-0.08
Lease Payments
-0.87-0.87--53.84-52.55-0.08
Total Debt Repaid
-279.43-283.33-333.57-263.04-338.55-135.08
Net Debt Issued (Repaid)
18.57-30.4313.5371.54-5.5859.1
Common Dividends Paid
-18.99-19.5-13.85-6.47-35.5-22.02
Other Financing Activities
-14.233.517.24--0.95-
Financing Cash Flow
-14.63-16.4316.9165.07-42.0337.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.020.02-0.010.020.01-0.06
Net Cash Flow
-42.7620.43-1.06-48.25-18.7311.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
5.4415.45-17.98-173.29-224.76-34.47
Free Cash Flow Growth
------
Free Cash Flow Margin
0.67%2.30%-3.56%-33.46%-42.69%-5.96%
Free Cash Flow Per Share
0.040.13-0.15-1.44-1.87-0.29
Levered Free Cash Flow
18.3685.37-15.15-176.9-232.921.51
Unlevered Free Cash Flow
19.4489.53-9.54-171.73-228.3626.19
Free Cash Flow After Leases
4.5714.58-17.98-227.13-277.31-34.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
109.4682.2546.5482.7967.1883.26
Change in Working Capital
-71.24-71.24-51.34-81.32-102.4534.31